Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Waller

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
British Journal of Clinical Pharmacology|October 1, 1986
Clinical and rheological effects of nifedipine in Raynaud's phenomenonD G Waller, V F Challenor, D A Francis, et al.
British Journal of Clinical Pharmacology|December 1, 1991
Gastric emptying in healthy volunteers after multiple doses of levodopaD G Waller, C Roseveare, A G Renwick, et al.
British Journal of Clinical Pharmacology|October 1, 1995
The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteersJ Roberts, D G Waller, N O'Shea, et al.
European Heart Journal|November 1, 1989
Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study GroupD G Waller, J Webster, C A Sykes, et al.
British Journal of Clinical Pharmacology|December 1, 1991
Oral amino acids and gastric emptying: an investigation of the mechanism of levodopa-induced gastric stasisD G Waller, F Usman, A G Renwick, et al.
European Journal of Clinical Pharmacology|January 1, 1997
The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard)J Armstrong, V F Challenor, B S Macklin, et al.
Platelets|November 4, 2010
Platelet Aggregation in Primary Raynaud's Phenomenon and the Effect of Enalapril AdministrationA Dowie, J L Francis, O S Roath, et al.
British Journal of Clinical Pharmacology|February 1, 1987
Food and nifedipine pharmacokineticsV F Challenor, D G Waller, B S Gruchy, et al.
British Journal of Clinical Pharmacology|November 1, 1993
Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juiceJ Rashid, C McKinstry, A G Renwick, et al.
Angiology|February 1, 1989
Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenonV F Challenor, D G Waller, R A Hayward, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Pharmacology|October 1, 1986
Clinical and rheological effects of nifedipine in Raynaud's phenomenonD G Waller, V F Challenor, D A Francis, et al.
British Journal of Clinical Pharmacology|December 1, 1991
Gastric emptying in healthy volunteers after multiple doses of levodopaD G Waller, C Roseveare, A G Renwick, et al.
British Journal of Clinical Pharmacology|October 1, 1995
The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteersJ Roberts, D G Waller, N O'Shea, et al.
European Heart Journal|November 1, 1989
Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study GroupD G Waller, J Webster, C A Sykes, et al.
British Journal of Clinical Pharmacology|December 1, 1991
Oral amino acids and gastric emptying: an investigation of the mechanism of levodopa-induced gastric stasisD G Waller, F Usman, A G Renwick, et al.
European Journal of Clinical Pharmacology|January 1, 1997
The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard)J Armstrong, V F Challenor, B S Macklin, et al.
Platelets|November 4, 2010
Platelet Aggregation in Primary Raynaud's Phenomenon and the Effect of Enalapril AdministrationA Dowie, J L Francis, O S Roath, et al.
British Journal of Clinical Pharmacology|February 1, 1987
Food and nifedipine pharmacokineticsV F Challenor, D G Waller, B S Gruchy, et al.
British Journal of Clinical Pharmacology|November 1, 1993
Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juiceJ Rashid, C McKinstry, A G Renwick, et al.
Angiology|February 1, 1989
Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenonV F Challenor, D G Waller, R A Hayward, et al.
Pageof 11